Two Sigma Investments LP Cuts Stake in AptarGroup, Inc. (NYSE:ATR)

Two Sigma Investments LP decreased its position in shares of AptarGroup, Inc. (NYSE:ATR - Free Report) by 33.3% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 43,597 shares of the industrial products company's stock after selling 21,790 shares during the period. Two Sigma Investments LP owned approximately 0.07% of AptarGroup worth $6,849,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Pictet Asset Management Holding SA raised its holdings in shares of AptarGroup by 13.7% during the 4th quarter. Pictet Asset Management Holding SA now owns 9,513 shares of the industrial products company's stock valued at $1,494,000 after buying an additional 1,146 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in shares of AptarGroup by 1.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,418 shares of the industrial products company's stock worth $1,480,000 after acquiring an additional 127 shares in the last quarter. Congress Asset Management Co. lifted its holdings in shares of AptarGroup by 4.1% in the 4th quarter. Congress Asset Management Co. now owns 703,308 shares of the industrial products company's stock worth $110,490,000 after acquiring an additional 27,614 shares during the last quarter. Mount Yale Investment Advisors LLC lifted its holdings in shares of AptarGroup by 288.5% in the 4th quarter. Mount Yale Investment Advisors LLC now owns 4,934 shares of the industrial products company's stock worth $775,000 after acquiring an additional 3,664 shares during the last quarter. Finally, Portfolio Design Labs LLC lifted its holdings in AptarGroup by 147.6% in the fourth quarter. Portfolio Design Labs LLC now owns 5,501 shares of the industrial products company's stock worth $864,000 after buying an additional 3,279 shares during the period. Hedge funds and other institutional investors own 88.52% of the company's stock.

AptarGroup Stock Down 0.4%

Shares of ATR stock traded down $0.70 during trading hours on Wednesday, hitting $157.46. 364,440 shares of the company's stock traded hands, compared to its average volume of 308,322. The stock's fifty day simple moving average is $148.85 and its two-hundred day simple moving average is $154.55. AptarGroup, Inc. has a 12-month low of $130.85 and a 12-month high of $178.03. The stock has a market cap of $10.40 billion, a price-to-earnings ratio of 28.42, a PEG ratio of 3.89 and a beta of 0.58. The company has a quick ratio of 0.95, a current ratio of 1.38 and a debt-to-equity ratio of 0.28.

AptarGroup (NYSE:ATR - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The industrial products company reported $1.20 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.04. The company had revenue of $887.31 million during the quarter, compared to the consensus estimate of $894.26 million. AptarGroup had a net margin of 10.45% and a return on equity of 15.56%. The firm's quarterly revenue was down 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.26 earnings per share. On average, analysts expect that AptarGroup, Inc. will post 5.57 EPS for the current year.

AptarGroup Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 22nd. Shareholders of record on Thursday, May 1st were given a $0.45 dividend. This represents a $1.80 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date of this dividend was Thursday, May 1st. AptarGroup's dividend payout ratio (DPR) is presently 32.85%.

Analysts Set New Price Targets

Several analysts have commented on ATR shares. Robert W. Baird lowered their price objective on shares of AptarGroup from $185.00 to $160.00 and set an "outperform" rating for the company in a report on Monday, February 10th. Raymond James lowered their price objective on shares of AptarGroup from $190.00 to $175.00 and set an "outperform" rating for the company in a report on Tuesday, April 22nd. Wells Fargo & Company restated an "overweight" rating and issued a $170.00 price objective (up from $162.00) on shares of AptarGroup in a report on Tuesday, May 6th. Finally, Wall Street Zen upgraded shares of AptarGroup from a "hold" rating to a "buy" rating in a report on Wednesday, May 14th. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Buy" and an average target price of $178.60.

Insiders Place Their Bets

In other news, insider Xiangwei Gong sold 7,000 shares of AptarGroup stock in a transaction on Thursday, May 22nd. The shares were sold at an average price of $156.49, for a total transaction of $1,095,430.00. Following the transaction, the insider now owns 10,265 shares in the company, valued at $1,606,369.85. This trade represents a 40.54% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Hedi Tlili sold 3,614 shares of AptarGroup stock in a transaction on Friday, May 16th. The stock was sold at an average price of $155.96, for a total transaction of $563,639.44. Following the transaction, the insider now owns 9,379 shares in the company, valued at $1,462,748.84. This represents a 27.81% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 40,709 shares of company stock valued at $6,224,840. Company insiders own 0.68% of the company's stock.

AptarGroup Profile

AptarGroup, Inc designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments.